Efficacy and safety of long-acting risperidone on early onset schizophrenia in adolescent patients
Received: 2020-01-12Accepted: 2025-10-13Published: 2020-01-12
Int. J. Pharm. & Pharmacol. 2018, 9(1), 1-6
© 2018 by author(s). Licensee MOSP, Macao, China. This is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license.
Disclaimer: The statements, opinions and data contained in this journal are solely those of the individual authors and contributors and not of Macao Scientific Publishers and/or the editors. Macao Scientific Publishers and/or the editors disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content.
